SAB Biotherapeutics Inc. (SABS) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for SAB Biotherapeutics Inc., updated every trading day.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Price
$3.20
+4.23% today
Market cap
$279M
Overall quality
—
Kronos AI 30-day
+18.0%
8 of 8 simulated paths end higher
SAB Biotherapeutics Inc. (SABS) is a Health Care company in Biotechnology: Biological Products (No Diagnostic Substances), worth $279M. It trades at $3.20, up 4.23% today. 2 analysts' average target of $12.67 implies +295.9% from today's price. Kronos AI's 30-day forecast is +18.0% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $12.67 |
| Low – high | $10.00 – $15.00 |
| Analysts | 2 |
| Upside to average | +295.9% |
Kronos AI 30-day forecast
| Expected close | $3.62 (+18.0%) |
| Likely range | +8.0% … +24.8% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Biological Products (No Diagnostic Substances)
For information only, not investment advice. Prices updated: 2026-10-29.